Literature DB >> 24655720

Serologic evidence of leptospirosis in humans, Union of the Comoros, 2011.

Yann Gomard, Rahamatou Silai, Géraldine Hoarau, Ketty Bon, Florelle Gonneau, Amina Yssouf, Alain Michault, Koussay Dellagi, Pablo Tortosa.   

Abstract

Entities:  

Keywords:  Leptospira; Union of the Comoros; bacteria; humans; leptospirosis; microscopic agglutination test; tropical islands; zoonoses

Mesh:

Year:  2014        PMID: 24655720      PMCID: PMC3966392          DOI: 10.3201/eid2004.131207

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Leptospirosis is a worldwide bacterial zoonosis caused by infection with pathogenic Leptospira spp. (Spirochaetales, Leptospiraceae). Most mammals can be infected, but rats are considered the main reservoir, maintaining Leptospira spirochetes in the lumen of renal tubules and contaminating the environment with bacteria-infected urine. Transmission to humans is accidental, occurring through contact with animal secretions or with contaminated environmental materials. In temperate countries, human leptospirosis is a sporadic disease; incidence is much higher in the tropics because climate and environmental conditions are conducive to the survival of bacteria, resulting in increased exposure of humans to leptospirosis-causing pathogens (). Among islands in the southwestern Indian Ocean, human leptospirosis is endemic to Mayotte, France, and La Réunion (–) and to the Seychelles, where the incidence of leptospirosis is one of the highest worldwide (). Leptospirosis is poorly documented in other islands in the region, including Mauritius, Madagascar, and the Union of the Comoros (,–). Whether the scant documentation indicates underdiagnosis or reflects local epidemiologic specificities is unknown. To improve knowledge of Leptospira infection in the region, we conducted a study in the Union of the Comoros to serologically assess the presence or absence of leptospirosis in humans. The Union of the Comoros consists of 3 islands: Grande-Comore, Mohéli, and Anjouan. Together with a fourth, southern island, Mayotte, these islands form the Comoros Archipelago. For feasibility reasons, we used excess serum samples. Seventy-six samples were from healthy volunteers who gave informed consent; 318 clinical blood samples from patients had been obtained by private laboratories and by the surveillance laboratory of the National Malaria Control Programme (PNLP) during August 1–October 8, 2011. The Ministère de la Santé, de la Solidarité et de la Promotion du Genre of the Union of the Comoros, authorized the serologic investigation (authorization no. 1175/MSSPG/DNS). We used the microscopic agglutination test (MAT) to test serum samples; the MAT was based on a panel of 15 Leptospira strains, enabling the screening of all recently reported serogroups for human and animal cases on neighboring Mayotte (,,). A list of the tested strains follows, shown as Genus species Serogroup/Serovar (type strain): L. borgpetersenii Ballum/Castellonis (Castellon 3), L. borgpetersenii Sejroe/Hardjobovis (Sponselee), L. borgpetersenii Sejroe/Sejroe (M 84), L. borgpetersenii Tarassovi/Tarassovi (Perepelicin), L. interrogans Australis/Australis (Ballico), L. interrogans Autumnalis/Autumnalis (Akiyami A), L. interrogans Bataviae/Bataviae (Van Tienen), L. interrogans Canicola/Canicola (Hond Utrecht IV), L. interrogans Hebdomadis/Hebdomadis (Hebdomadis), L. interrogans Icterohaemorrhagiae/Copenhageni (Wijnberg), L. interrogans Pyrogenes/Pyrogenes (Salinem), L. kirschneri Cynopteri/Cynopteri (3522C), L. kirschneri Grippotyphosa/Grippotyphosa (Moskva V), L. kirschneri Mini/Undetermined serovar (200803703) (), L. noguchii Panama/Panama (CZ214K). Each serum sample was tested at dilutions ranging from 1:50 to 1:3,200 and considered positive when the MAT titer was >100. Our serologic findings showed evidence of Leptospira infection in humans on the 3 islands of the Union of the Comoros (MAT titers 100–1,600, geometric mean titer [GMT] 194). The positivity rate was 10.3% (95% CI 4.8–15.9) for samples from Mohéli, 4.2% (95% CI 1.4–7.0) for samples from Grande-Comore, and 3.4% (95% CI 0.1–6.7) for samples from Anjouan; no significant difference was found between islands or by the age or sex of residents (p>0.05, Fisher exact test). Leptospira infection was more prevalent and MAT titers were higher among serum samples from the patient group than the healthy donor group (20 positive samples/318 total vs. 3 positive samples/76 total; GMT 207 vs. GMT 126), but the difference was not significant (p>0.05, Fisher exact test). In 78% of seropositive serum samples, antibodies reacted with serogroups Australis, Bataviae, Grippotyphosa, Panama, Pomona, Pyrogenes, Mini, and/or Sejroe. MAT titers >100, which are suggestive of more specific antibodies to Leptospira, were observed for all serogroups except Australis and Sejroe. Pyrogenes serogroup was identified in one third of positive samples from Mohéli and was associated with the highest agglutination titers (Figure).
Figure

Microagglutination test results, showing serologic evidence of leptospirosis in humans, Union of the Comoros, 2011. The percentage of positive cases is shown for each island; the number below the percentage indicates the number of positive serum samples/total number tested. The serogroups identified on each island are shown; numbers represent the number of positive serum samples and, in parentheses, the number of corresponding titers. When agglutination was observed with >1 serogroup, the serogroup with a titer difference >2 relative to other serogroups was considered to be the infecting serogroup; when no serogroup had a titer difference >2 relative to other serogroups, coagglutinins were considered to be present in the serum sample. Data for Mayotte Island are from previous studies (,).

Microagglutination test results, showing serologic evidence of leptospirosis in humans, Union of the Comoros, 2011. The percentage of positive cases is shown for each island; the number below the percentage indicates the number of positive serum samples/total number tested. The serogroups identified on each island are shown; numbers represent the number of positive serum samples and, in parentheses, the number of corresponding titers. When agglutination was observed with >1 serogroup, the serogroup with a titer difference >2 relative to other serogroups was considered to be the infecting serogroup; when no serogroup had a titer difference >2 relative to other serogroups, coagglutinins were considered to be present in the serum sample. Data for Mayotte Island are from previous studies (,). Our data indicate that Leptospira infections do occur in humans in the Union of the Comoros; this finding is consistent with those in studies reporting leptospirosis in persons returning from travel in the Union of the Comoros (,) and with the detection of pathogenic Leptospira spp. in bats sampled on these islands (). The human leptospirosis–related serologic findings in Union of Comoros are most comparable to those from neighboring Mayotte, where leptospirosis is mainly caused by serogroups Mini/Sejroe/Hebdomadis complex, Pyrogenes, Grippotyphosa, and Pomona and where serogroup Icterohaemorraghiae is not detectable (). These findings contrast with human leptospirosis findings from La Réunion and the Seychelles, where the Icterohaemorraghiae serogroup is most common (). Our MAT-derived data cannot discriminate between recent and past Leptospira infections, nor can these data be used to determine the severity of the disease in the Union of the Comoros. Nonetheless, the data strongly support the presence of human leptospirosis on the 3 islands of the Union of the Comoros and emphasize the need for a proper diagnosis to ascertain the number of leptospirosis cases among the acute febrile illnesses in this country.
  10 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Human leptospira isolates circulating in Mayotte (Indian Ocean) have unique serological and molecular features.

Authors:  P Bourhy; L Collet; T Lernout; F Zinini; R A Hartskeerl; Hans van der Linden; J M Thiberge; L Diancourt; S Brisse; C Giry; F Pettinelli; M Picardeau
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

3.  Leptospirosis in a French traveler returning from Mauritius.

Authors:  Fabrice Simon; Gabriel Morand; Céline Roche; Thierry Coton; Philippe Kraemer; Pierre-Edouard Fournier; Philippe Gautret
Journal:  J Travel Med       Date:  2011-12-08       Impact factor: 8.490

Review 4.  The globalization of leptospirosis: worldwide incidence trends.

Authors:  Georgios Pappas; Photini Papadimitriou; Vasiliki Siozopoulou; Leonidas Christou; Nikolaos Akritidis
Journal:  Int J Infect Dis       Date:  2007-12-04       Impact factor: 3.623

5.  Strikes, flooding, rats, and leptospirosis in Marseille, France.

Authors:  Cristina Socolovschi; Emmanouil Angelakis; Aurélie Renvoisé; Pierre-Edouard Fournier; Jean Lou Marié; Bernard Davoust; Andreas Stein; Didier Raoult
Journal:  Int J Infect Dis       Date:  2011-07-20       Impact factor: 3.623

6.  Similarities in Leptospira serogroup and species distribution in animals and humans in the Indian ocean island of Mayotte.

Authors:  Amélie Desvars; Florence Naze; Gwenaël Vourc'h; Eric Cardinale; Mathieu Picardeau; Alain Michault; Pascale Bourhy
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

7.  Isolation and characterization of new Leptospira genotypes from patients in Mayotte (Indian Ocean).

Authors:  Pascale Bourhy; Louis Collet; Sabine Clément; Michel Huerre; Patrick Ave; Claude Giry; François Pettinelli; Mathieu Picardeau
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

Review 8.  Diagnosis and epidemiology of leptospirosis.

Authors:  M Picardeau
Journal:  Med Mal Infect       Date:  2013-01-18       Impact factor: 2.152

9.  Pathogenic Leptospira spp. in bats, Madagascar and Union of the Comoros.

Authors:  Erwan Lagadec; Yann Gomard; Vanina Guernier; Muriel Dietrich; Hervé Pascalis; Sarah Temmam; Beza Ramasindrazana; Steven M Goodman; Pablo Tortosa; Koussay Dellagi
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

10.  First isolation and direct evidence for the existence of large small-mammal reservoirs of Leptospira sp. in Madagascar.

Authors:  Soanandrasana Rahelinirina; Albertine Léon; Rudy A Harstskeerl; Natacha Sertour; Ahmed Ahmed; Claudine Raharimanana; Elisabeth Ferquel; Martine Garnier; Loïc Chartier; Jean-Marc Duplantier; Lila Rahalison; Muriel Cornet
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

  10 in total
  4 in total

1.  Has Madagascar lost its exceptional leptospirosis free-like status?

Authors:  Maherisoa Ratsitorahina; Soanandrasana Rahelinirina; Alain Michault; Minoarisoa Rajerison; Soatiana Rajatonirina; Vincent Richard
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

2.  Human leptospirosis in Seychelles: A prospective study confirms the heavy burden of the disease but suggests that rats are not the main reservoir.

Authors:  Leon Biscornet; Koussay Dellagi; Frédéric Pagès; Jastin Bibi; Jeanine de Comarmond; Julien Mélade; Graham Govinden; Maria Tirant; Yann Gomard; Vanina Guernier; Erwan Lagadec; Jimmy Mélanie; Gérard Rocamora; Gildas Le Minter; Julien Jaubert; Patrick Mavingui; Pablo Tortosa
Journal:  PLoS Negl Trop Dis       Date:  2017-08-28

3.  Human Leptospirosis on Reunion Island, Indian Ocean: Are Rodents the (Only) Ones to Blame?

Authors:  Vanina Guernier; Erwan Lagadec; Colette Cordonin; Gildas Le Minter; Yann Gomard; Frédéric Pagès; Marie-Christine Jaffar-Bandjee; Alain Michault; Pablo Tortosa; Koussay Dellagi
Journal:  PLoS Negl Trop Dis       Date:  2016-06-13

4.  Biogeography of Leptospira in wild animal communities inhabiting the insular ecosystem of the western Indian Ocean islands and neighboring Africa.

Authors:  Muriel Dietrich; Yann Gomard; Erwan Lagadec; Beza Ramasindrazana; Gildas Le Minter; Vanina Guernier; Aude Benlali; Gerard Rocamora; Wanda Markotter; Steven M Goodman; Koussay Dellagi; Pablo Tortosa
Journal:  Emerg Microbes Infect       Date:  2018-04-04       Impact factor: 7.163

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.